Improved radiological outcome of rheumatoid arthritis: The importance of early treatment with methotrexate in the era of biological drugs

Clinical Rheumatology

Volumn 32, Issue 12, 2013, Pages 1735-1742

  Fiehn, Christoph ^a   Belke Voss, Elisabeth ^a   Krause, Dietmar ^b   Wassenberg, Siegfried ^c   Rau, Rolf ^c  

^a ACURA Centre for Rheumatic Diseases   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Evangelisches Fach krankenhaus Ratingen   (Germany)

Author keywords

Biologic drugs; Erosions; Methotrexate; Outcome; Rheumatoid arthritis

Indexed keywords

AURANOFIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CONSULTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RATINGEN SCORE; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84890434007     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2325-0     Document Type: Article

References (21)

1. Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis 69(10):1803-1808
2. Pincus T, Sokka T, Kautiainen H (2005) Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 52(4):1009-1019
3. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J et al (2000) The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 39(2):122-132
4. Finckh A, Choi HK, Wolfe F (2006) Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 65(9):1192-1197
5. Sokka T, Kautiainen H, Hakkinen A, Hannonen P (2004) Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol 31(6):1073-1082
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
7. Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A (1998) A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 25(11):2094-2107
8. Rau R, Herborn G (1995) A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22(10):1976-1982
9. Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J (1991) A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 18(3):328-333
10. Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over 2 years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52(11):3371-3380
11. Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN (1995) TNF-alpha is an effective therapeutic target for rheumatoid arthritis. Ann NY Acad Sci 766:272-278
12. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313):1173-1177
13. Krause D, Schleusser B, Herborn G, Rau R (2000) Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 43(1):14-21
14. Reiss AB, Carsons SE, Anwar K, Rao S, Edelman SD, Zhang H et al (2008) Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis Rheum 58(12):3675-3683
15. Jeurissen ME, Boerbooms AM, van de Putte LB, Doesburg WH, Lemmens AM (1991) Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med 114(12):999-1004
16. Reykdal S, Steinsson K, Sigurjonsson K, Brekkan A (1989) Methotrexate treatment of rheumatoid arthritis: effects on radiological progression. Scand J Rheumatol 18(4):221-226
17. Nordstrom DM, West SG, Andersen PA, Sharp JT (1987) Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 107(6):797-801
18. Rau R, Herborn G, Karger T, Werdier D (1991) Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study. Arthritis Rheum 34(10):1236-1244
19. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D et al (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372(9636):375-382
20. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van VR (2006) The premier study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54(1):26-37
21. Furst DE (2010) Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 28(3 Suppl 59):S5-S12